More than one-fifth of patients with COVID-19 presenting with neurologic findings who underwent neuroimaging had critical findings, according to a study scheduled for presentation at the annual meeting of the Radiological Society of North America, held virtually from Nov. 29 to Dec. 5.
Colbey W. Freeman, M.D., from the Perelman School of Medicine at the University of Pennsylvania in Philadelphia, and colleagues examined use of neuroimaging in patients with COVID-19 presenting with neurologic complications. Overall, 1,357 severe acute respiratory syndrome coronavirus 2-positive patients were admitted; 81 (6 percent) underwent neuroimaging.